TORONTO, Nov. 13, 2012 /CNW/ - Centric Health Corporation ("Centric Health" or "the Company") (TSX:
CHH), Canada's leading diversified healthcare services company, today
announced financial results for the third quarter ended September 30,
2012.
Financial and Operating Highlights for the Third Quarter and Year to
Date 2012
-
Revenue increased by 60% to $107.4 million for the third quarter and by
163% to $325.7 million for the year to date from the prior year
periods, the result of acquisitions and organic growth;
-
Adjusted EBITDA1 increased to $33.2 million for the year to date from $15.0 million for
the prior year period due to acquisitions, cost containment initiatives
and organic growth;
-
Adjusted EBITDA1 decreased to $9.0 million for third quarter from $9.7 million for the
prior year period due to the impact of regulatory changes in the
assessments segment ($0.9 million), increased corporate overhead costs
($1.0 million) and lower utilization of operating room capacity in the
surgical segment ($0.8 million);
-
Generated $3.4 million in positive cash flow from operations for the
third quarter as a result of the Company's continued focus on cash
management;
-
Completed bought deal offering of convertible unsecured subordinated
notes generating net proceeds of $25.9 million, including the
over-allotment option;
-
Appointed David Cutler as President, Chief Executive Officer and a
member of the Board of Directors of the Company; and,
-
The Company continued its focus on cost containment with further
integration, rationalization, renegotiation of supplier contracts and
the closure and rationalization of certain assessment locations. The
Company expects to realize annualized savings of $6.0 million to $7.5
million through these initiatives. Several top line initiatives have
commenced to extract synergies and expand operations throughout the
Company.
"Centric Health has assembled an irreplaceable platform to deliver the
highest quality of patient care and create value for all stakeholders,"
said David Cutler, President and Chief Executive Officer, Centric
Health Corporation. "In my new position, one of my top priorities is
to establish the systems, structure and processes, and appoint a
permanent COO and CIO, to enable us to fully capitalize on the
significant opportunities inherent in our business. At the same time,
we are executing on strategies across our organization to drive
long-term growth, with particular emphasis on our bundled services
offering to seniors care homes and multiple initiatives to leverage the
excess capacity at our Surgical and Medical Centres. We are making
strong initial progress, having recently signed several new bundled
services contracts and launched our first surgical Centres of
Excellence, and expect to realize meaningful contributions next year."
"Despite the softer quarter emphasized by seasonality, the Company
expects to yield meaningful improvements in financial performance in
future quarters through operational efficiencies, top line initiatives
and rationalization and cost containments effected in 2012," said Peter
Walkey, Chief Financial Officer, Centric Health Corporation. "Our
continued focus on the integration of our acquired business has
resulted in a meaningful decrease in corporate office expenses as a
proportion of revenue so far in 2012. In addition, we generated
positive cash flow from operations of $3.4 million, the result of our
cash flow management efforts."
________________________________
1Defined and calculated in Reconciliation of Non-IFRS Measures
FINANCIAL RESULTS
(All amounts below are in thousands except per share, shares
outstanding, and percentage data)
Selected Financial Information
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|
2012
|
2011
|
2012
|
2011
|
|
$
|
$
|
$
|
$
|
Revenue
|
107,358
|
67,096
|
325,734
|
123,727
|
|
|
|
|
|
Income from operations
|
2,273
|
8,428
|
13,895
|
12,809
|
% of revenue
|
2.1%
|
12.6%
|
4.3%
|
10.4%
|
|
|
|
|
|
EBITDA1
|
6,827
|
48,190
|
69,870
|
58,159
|
|
|
|
|
|
Adjusted EBITDA1
|
9,008
|
9,689
|
33,241
|
15,093
|
Adjusted EBITDA1 margin
|
8.4%
|
14.4%
|
10.2%
|
12.2%
|
|
|
|
|
|
Net (loss) income
|
(6,273)
|
38,889
|
31,442
|
43,486
|
Per share - basic ($)
|
$ (0.05)
|
$ 0.47
|
$ 0.28
|
$ 0.56
|
Per share - diluted ($)
|
$ (0.05)
|
$ 0.37
|
$ 0.24
|
$ 0.45
|
|
|
|
|
|
Weighted average shares
|
|
|
|
|
outstanding
|
116,856
|
83,156
|
111,714
|
77,285
|
Shares outstanding Sept. 30
|
121,318
|
84,433
|
121,318
|
84,433
|
Consolidated Results
Consolidated revenue for the third quarter of 2012 increased by 60% to
$107.4 million from $67.1 million for the comparable period of 2011.
The increase is primarily the result of several notable acquisitions,
as well as organic growth.
Adjusted EBITDA1, which excludes transaction and restructuring costs and the non-cash
change in the fair value of the contingent consideration liability, for
the third quarter of 2012 was $9.0 million compared with $9.7 million
for the comparable period of 2011. The change is primarily due to the
impact of regulatory changes in the assessments segment ($0.9 million),
increased corporate overhead costs associated with the sizable Classic
Care and Motion acquisitions ($1.0 million) and lower utilization of
operating room capacity in the surgical segment ($0.8 million).
Adjusted EBITDA1 margin for the third quarter of 2012 was 8.4% compared with 14.4% for
the comparable period of 2011.
Consolidated revenue and Adjusted EBITDA1 for the third quarter of 2012 decreased from $114.1 million and $12.5
million, respectively, in the second quarter of 2012, primarily due to
seasonality at certain of the Company's operations, including fewer
physiotherapy treatments as patients take more personal vacation over
the summer months and certain surgical centres being either closed or
having fewer procedures due to surgeon vacations.
Consolidated revenue for the first nine months of 2012 increased by 163%
to $325.7 million from $123.7 million for the comparable period of
2011. Adjusted EBITDA1 for the first nine months of 2012 increased by 120% to $33.2 million
from $15.1 million for the comparable period of 2011. Adjusted EBITDA1 margin for the first nine months of 2012 was 10.2% compared with 12.2%
for the comparable period of 2011. The lower margins are a result of
the acquisitions of Motion Specialties and Classic Care, which generate
lower margins as compared to the Company's legacy operations.
Segment Results
|
|
Three months ended September 30,
|
|
|
Revenue
|
Adjusted EBITDA1
|
|
|
|
2012
|
2011
|
2012
|
|
2011
|
|
|
|
$
|
$
|
$
|
%
|
$
|
%
|
Physiotherapy
|
|
42,210
|
40,479
|
5,497
|
13.0
|
5,660
|
14.0
|
Pharmacy
|
|
22,429
|
3,883
|
2,357
|
10.5
|
1,074
|
27.7
|
Retail &Home Medical Equipment
|
|
26,176
|
2,553
|
1,646
|
6.3
|
771
|
30.2
|
Assessments
|
|
8,712
|
12,606
|
1,624
|
18.6
|
2,495
|
19.8
|
Surgical & Medical Centres
|
|
7,831
|
7,575
|
340
|
4.3
|
1,125
|
14.9
|
Corporate
|
|
-
|
-
|
(2,456)
|
-
|
(1,436)
|
-
|
Total
|
|
$ 107,358
|
$ 67,096
|
$ 9,008
|
8.4%
|
$ 9,689
|
14.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30,
|
|
|
Revenue
|
|
Adjusted EBITDA1
|
|
|
|
2012
|
2011
|
2012
|
|
2011
|
|
|
|
$
|
$
|
$
|
%
|
$
|
%
|
Physiotherapy
|
|
132,898
|
71,737
|
19,756
|
14.9
|
9,452
|
13.2
|
Pharmacy*
|
|
69,109
|
6,018
|
7,312
|
10.6
|
1,108
|
18.4
|
Retail &Home Medical Equipment*
|
|
69,643
|
3,259
|
5,525
|
7.9
|
1,081
|
33.2
|
Assessments
|
|
28,380
|
24,500
|
4,976
|
17.5
|
5,320
|
21.7
|
Surgical & Medical Centres*
|
|
25,704
|
18,213
|
2,608
|
10.1
|
2,544
|
14.0
|
Corporate
|
|
-
|
-
|
(6,936)
|
-
|
(4,412)
|
-
|
Total
|
|
$ 325,724
|
$ 123,727
|
$ 33,241
|
10.2
|
$ 15,093
|
12.2
|
* - Adjusted EBITDA margins reflect acquisitions since the third quarter
of 2011 which generate lower margins than legacy operations.
The year-over-year decrease in Adjusted EBITDA1 for the Physiotherapy segment for the third quarter of 2012 is
primarily the result of a higher than anticipated decline in the number
of physiotherapy patients treated over the summer months. The third
quarter is typically a softer quarter for the Company's physiotherapy
clinics as patients tend to have fewer treatments due to their personal
vacation schedules.
The year-over-year decrease in Adjusted EBITDA1 margin for the Retail and Home Medical Equipment segment for the third
quarter of 2012 is attributable to the acquisition during the first
quarter of 2012 of Motion Specialties, which generates lower margins
than the MEDIchair franchise royalty fees. With combined purchasing
power benefits and certain rationalization initiatives, Adjusted EBITDA1 margin is expected to improve in the future.
Revenue and Adjusted EBITDA1 for the Assessments segment for the third quarter of 2012 continued to
be adversely affected by legislative changes surrounding automobile
insurance coverage. The Company continues to right-size the
Assessments operations to improve its margins and during the third
quarter consolidated its Ontario operations into fewer assessments
centres. The Assessments segment continues to generate positive income
and cash flows. The Company has been successful in continuing to win
RFPs for the provision of assessment services, and is well positioned
competitively to increase its market share based on its size and
national presence.
The year-over-year decrease in Adjusted EBITDA1 for the Surgical and Medical Centres segment for the third quarter of
2012 is mainly due to low utilization of operating room capacity as a
result of renovations, closures, and surgeon vacations. The Company is
pursuing innovative strategies including the launch of the Company's
first surgical Centre of Excellence in October 2012 in orthopedic
surgery. The Company expects to launch further specialized surgical
Centres of Excellence over the coming year which will partner the
Company with some of Canada's leading surgeons. The Company also has
long-term initiatives to launch triage assessment programs, new
treatment technologies, an extended patient choice network and
transitional care maternity beds.
SHARES OUTSTANDING
As at both September 30, 2012 and the date of this news release, the
Company has total shares outstanding of 144,549,097, of which
23,231,081 are held in escrow pending acquired businesses achieving
performance targets or vesting milestones. Consequently, there are
121,318,016 shares outstanding excluding restricted shares and shares
held in escrow as contingent consideration for the vendors of acquired
businesses. The number of options outstanding is 11,690,500, the
number of warrants outstanding is 28,576,590, and the number of
restricted share units outstanding is 615,000. Should all outstanding
options and warrants that were exercisable at September 30, 2012 be
exercised, the Company would receive proceeds of $16,942.
LIQUIDITY AND CAPITAL RESOURCES
The Company was in compliance with its financial performance covenants
at September 30, 2012. The Company anticipates that based on its
expected fourth quarter operating results, its 2013 operating budget
and working capital initiatives, it will generate sufficient cash flows
to meet its financial performance covenants and other obligations as
they come due.
OUTLOOK
In addition to its acquisition strategy, the Company is focused on
organic growth initiatives, including cross-selling activities and new
service introductions across its business segments. Many of these
organic growth initiatives are in their infancy stages and the benefits
are not expected to be realized until 2013 due to long sales cycles.
One of the largest and most advanced opportunities is bundled service
contracts to long term care and retirement homes. The Company has
recently signed several such contracts and further contracts are
expected to be signed in the coming quarters. In addition, utilization
within the Surgical and Medical Centres remains low and presents a
high-margin growth opportunity as operations already are above the
break-even point and the Company will leverage off its already fixed
asset cost base. The Company has multiple initiatives to capitalize on
this excess capacity and recently launched the first of many planned
surgical Centres of Excellence (COEs) and plans to launch additional
COEs in 2013 and beyond. Other initiatives include increasing retail
sales, rolling out orthotics and expanding massage therapy within the
Physiotherapy network.
With the completion of over 15 acquisitions over the past two years, the
Company is also focused on integration and rationalization to bring
these businesses together under a common strategy. Near-term
priorities in this regard include the appointment of a permanent Chief
Operating Officer and Chief Information Officer. In addition, the
Company continues to focus on operational efficiency to improve margins
and has undertaken several special projects to achieve economies of
scale and rationalization benefits, which it expects to continue to
realize in the fourth quarter of 2012 and into 2013.
1Non-IFRS Measures
This press release includes certain measures which have not been
prepared in accordance with IFRS such as EBITDA, Adjusted EBITDA and
Adjusted EBITDA per share. These non-IFRS measures are not recognized
under IFRS and, accordingly, shareholders are cautioned that these
measures should not be construed as alternatives to net income
determined in accordance with IFRS. The Company defines EBITDA as
earnings before depreciation and amortization, interest expense, change
in fair value of derivative financial instruments, loss on disposal of
property and equipment, stock based compensation, amortization of lease
incentives, and income tax (recovery) expense. Adjusted EBITDA is
defined as EBITDA before transaction and restructuring costs and
changes in the fair value of the contingent consideration liability
recognized in the statement of income. Adjusted EBITDA % is defined as
Adjusted EBITDA divided by revenue. Adjusted EBITDA per share is
defined as Adjusted EBITDA divided by the weighted outstanding shares
on both a basic and diluted basis. The Company believes that Adjusted
EBITDA is a meaningful financial metric as it assists in the ability to
measure cash generated from operations. EBITDA and Adjusted EBITDA are
not recognized measures under IFRS.
Reconciliation of Non-IFRS Measures
|
Three months ended
September 30,
|
Nine months ended
September 30,
|
|
2012
$
|
2011
$
|
2012
$
|
2011
$
|
Net (loss) income
|
(6,273)
|
38,889
|
31,442
|
43,486
|
|
Depreciation and amortization
|
6,563
|
1,270
|
19,115
|
2,305
|
|
Interest expense
|
7,134
|
5,018
|
17,788
|
7,489
|
|
Change in fair value of derivative financial instruments
|
(261)
|
1,580
|
(418)
|
1,485
|
|
Loss on disposal of property and equipment
|
-
|
-
|
44
|
-
|
|
Stock-based compensation expense
|
1,266
|
817
|
2,952
|
1,794
|
|
Amortization of lease incentives
|
172
|
(9)
|
231
|
(21)
|
|
Income tax (recovery) expense
|
(1,774)
|
625
|
(1,284)
|
1,621
|
EBITDA1
|
6,827
|
48,190
|
68,870
|
58,159
|
|
Transaction and restructuring costs
|
3,861
|
873
|
8,642
|
4,554
|
|
Change in fair value of contingent consideration liability
|
(1,680)
|
(39,374)
|
(45,271)
|
(47,620)
|
Adjusted EBITDA1
|
9,008
|
9,689
|
33,241
|
15,093
|
|
|
|
|
|
Basic weighted average number of shares
|
116,856
|
83,156
|
111,714
|
77,285
|
Adjusted EBITDA1 per share (basic)
|
$0.08
|
$0.12
|
$
|
0.30
|
$
|
0.20
|
Fully diluted weighted average number of shares
|
130,414
|
105,053
|
129,635
|
97,531
|
Adjusted EBITDA1 per share (diluted)
|
$0.07
|
$0.09
|
$
|
0.26
|
$
|
0.15
|
CONFERENCE CALL
Centric Health will host a conference call, including a slide
presentation, to discuss its third quarter 2012 financial results
today, Tuesday, November 13, 2012, at 8:30 a.m. (ET).
Telephone Dial-In Access Information
To access the conference call by telephone, dial 647-427-7450 or
1-888-231-8191. Please connect approximately 10 minutes prior to the
beginning of the call to ensure participation. Those participating in
the conference call by telephone can view the slide presentation by
accessing the online webcast (see instructions below) and choosing the
Non-Streaming Audio option.
Webcast Access Information
A live webcast of the conference call, including the slide presentation,
will be available on the Events and Presentations page of the Investors
section of the Company's web site (http://www.centrichealth.ca/events-presentations.php). Please connect at least 15 minutes prior to the conference call to
ensure adequate time for any software download that may be required to
join the webcast. To view the webcast presentation with slides, please
choose either the Real Streaming Audio or Windows Streaming Audio
option.
Archive Access Information
The conference call will be archived for replay by telephone until
Tuesday, November 20, 2012 at midnight. To access the archived
conference call, dial 1-855-859-2056 and enter the reservation number
68298951.
The webcast with slide presentation will be archived for 90 days on the
Events and Presentations page of the Investors section of the Company's
web site (http://www.centrichealth.ca/events-presentations.php).
For further information please refer to the Company's complete filings
at www.sedar.com.
About Centric Health
Centric Health is Canada's leading diversified healthcare company and
dedicated to building on the strengths of Canada's healthcare system
through innovative solutions. Through a series of strategic
acquisitions, the Company has amassed a national platform for delivery
of a broad range of services through more than 3,600 staff and
consultants at almost 1,000 locations and has preferred provider
contracts with over 50 corporations, government agencies and employers,
and over 600 contracts with Long Term Care and Retirement Homes. This
platform provides compelling growth prospects through synergies,
rationalization and cross-pollination opportunities to create
meaningful value for all stakeholders. Above all, Centric Health has
an unwavering commitment to employ the highest service and ethical
standards and deliver a superior quality of care with the best possible
clinical outcomes. For more information, visit www.centrichealth.ca.
This press release contains statements that may constitute
"forward-looking statements" within the meaning of applicable Canadian
securities legislation. These forward-looking statements include,
among others, statements regarding business strategy, plans and other
expectations, beliefs, goals, objectives, information and statements
about possible future events. Readers are cautioned not to place undue
reliance on such forward-looking statements. Forward-looking statements
are based on current expectations, estimates and assumptions that
involve a number of risks, which could cause actual results to vary and
in some instances to differ materially from those anticipated by
Centric Health and described in the forward-looking statements
contained in this press release. No assurance can be given that any of
the events anticipated by the forward-looking statements will transpire
or occur or, if any of them do so, what benefits Centric Health will
derive there-from.
SOURCE: Centric Health Corporation